de Verneuil Vanina sold VIR

November 5, 2025 · Form 4 insider transaction

de Verneuil Vanina sold 2,385 shares of Vir Biotechnology, Inc. at $5.16 per share, a transaction worth $12.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
2,385
Price
$5.16
Total value
$12.3K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 5, 2025
Filing dateNovember 7, 2025
Shares owned after78,210
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 5, 2024.

View the original Form 4 on SEC EDGAR